Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lignum aquilariae resinatum
- Development stage
- Unknown
- Lead developer
- Tianjin Lerentang Pharmaceutical Factory
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lignum Aquilariae Resinatum (ALR), commonly known as Agarwood or Chen Xiang, is a traditional Chinese medicine derived from the resinous heartwood of *Aquilaria agallocha* or *Aquilaria sinensis*. It is primarily utilized for the treatment of gastrointestinal disorders, including stomachaches, emesis, and chemotherapy-induced intestinal mucositis. ALR exerts its therapeutic effects through multiple mechanisms: it acts as a spasmolytic by inhibiting muscarinic receptors, blocking calcium influx, and promoting nitric oxide release. Additionally, it possesses anti-inflammatory properties by inhibiting cyclooxygenase-2 (COX-2) and tumor necrosis factor-alpha (TNF-α), and it supports mucosal repair by up-regulating proliferating cell nuclear antigen (PCNA). It is typically prepared as an extract and has been studied for its protective effects against 5-fluorouracil-induced intestinal damage.
- Other names
- Aquilaria lignumAgarwoodChen Xiangresinous heartwood of Aquilaria agallochaLignum Aquilariae
02
Targets
AcetylcholinesterasePTGS2 (Prostaglandin-Endoperoxide Synthase 2)mAChR (Muscarinic acetylcholine receptors)PCNA (Proliferating cell nuclear antigen)TNFA (Tumor necrosis factor alpha (soluble))CaV (Voltage-gated calcium channel protein complex)NO2- (Nitrite)
Beyond the preview
Go deeper on lignum aquilariae resinatum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lignum aquilariae resinatum.